Novo Nordisk A/S-BNONOF
13F holders, Q1 2025 (March 31)2holders −1
0new positions
1sold out
$68.11avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Novo Nordisk A/S-B (NONOF) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were LBMC Investment Advisors, LLC ($494K) and Atlas Capital Advisors Inc. ($355K).
- Company
- Novo Nordisk A/S-B
- CUSIP
- K72807140
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $67K |
All 13F filers, Q4 2024 → Q1 2025: 3,738 shares sold, net −3,738 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| LBMC Investment Advisors, LLC | 0.04% | Reduce -29.0% | 7,250 | $494K |
| Atlas Capital Advisors Inc. | 0.04% | No change | 5,218 | $355K |
"% of holder's portfolio" is NONOF's weight in each manager's 13F, not the share of Novo Nordisk A/S-B the manager owns.